"Polymyositis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diseases characterized by inflammation involving multiple muscles. This may occur as an acute or chronic condition associated with medication toxicity (DRUG TOXICITY); CONNECTIVE TISSUE DISEASES; infections; malignant NEOPLASMS; and other disorders. The term polymyositis is frequently used to refer to a specific clinical entity characterized by subacute or slowly progressing symmetrical weakness primarily affecting the proximal limb and trunk muscles. The illness may occur at any age, but is most frequent in the fourth to sixth decade of life. Weakness of pharyngeal and laryngeal muscles, interstitial lung disease, and inflammation of the myocardium may also occur. Muscle biopsy reveals widespread destruction of segments of muscle fibers and an inflammatory cellular response. (Adams et al., Principles of Neurology, 6th ed, pp1404-9)
| Descriptor ID |
D017285
|
| MeSH Number(s) |
C05.651.594.819 C10.668.491.562.575
|
| Concept/Terms |
Polymyositis- Polymyositis
- Polymyositides
- Myositis, Multiple
- Multiple Myositis
- Myositides, Multiple
Polymyositis, Idiopathic- Polymyositis, Idiopathic
- Idiopathic Polymyositides
- Idiopathic Polymyositis
- Polymyositides, Idiopathic
|
Below are MeSH descriptors whose meaning is more general than "Polymyositis".
Below are MeSH descriptors whose meaning is more specific than "Polymyositis".
This graph shows the total number of publications written about "Polymyositis" by people in this website by year, and whether "Polymyositis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 2 | 0 | 2 |
| 2018 | 5 | 1 | 6 |
| 2019 | 2 | 0 | 2 |
| 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Polymyositis" by people in Profiles.
-
AstraZeneca (AZD1222) COVID-19 vaccine-associated adverse drug event: A case report. J Med Virol. 2021 Oct; 93(10):5718-5720.
-
COVID-19 and myositis - unique challenges for patients. Rheumatology (Oxford). 2021 02 01; 60(2):907-910.
-
Anti-Ku syndrome with elevated CK: association with myocardial involvement in systemic sclerosis. Ann Rheum Dis. 2021 07; 80(7):e113.
-
Response to 'Augmented vs. artificial intelligence for stratification of patients with myositis' by Mahler et al. Ann Rheum Dis. 2020 12; 79(12):e163.
-
Muscle endurance deficits in myositis patients despite normal manual muscle testing scores. Muscle Nerve. 2019 01; 59(1):70-75.
-
Effect of CTLA4-Ig (abatacept) treatment on T cells and B cells in peripheral blood of patients with polymyositis and dermatomyositis. Scand J Immunol. 2019 Jan; 89(1):e12732.
-
Expression of interleukin-18 in muscle tissue of patients with polymyositis or dermatomyositis and effects of conventional immunosuppressive treatment. Rheumatology (Oxford). 2018 12 01; 57(12):2149-2157.
-
Radiological images of interstitial pneumonia in mixed connective tissue disease compared with scleroderma and polymyositis/dermatomyositis. Eur J Radiol. 2018 Oct; 107:26-32.
-
Treatment of inflammatory myopathies. Expert Rev Clin Immunol. 2018 07; 14(7):607-621.
-
Prevalence and predictors of asymptomatic vertebral fractures in inflammatory myositis. Int J Rheum Dis. 2018 Mar; 21(3):725-731.